Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bonifati

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Clinical and Experimental Dermatology|December 3, 2014
Clinical remission of psoriatic arthritis in patients receiving continuous biological therapies for 1 year: the experience of an outpatient dermatological clinic for psoriasisD Graceffa, E Maiani, I Sperduti, et al.
Journal of Biological Regulators and Homeostatic Agents|May 16, 1998
IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skinC Bonifati, M Carducci, A Mussi, et al.
Drugs & Aging|April 16, 1998
Recognition and treatment of psoriasis. Special considerations in elderly patientsC Bonifati, M Carducci, A Mussi, et al.
Archives of Dermatological Research|January 1, 1994
sICAM-1, sIL-2R and beta 2-microglobulin serum levels in patients affected with psoriasis: relationship with disease severityM Carducci, A Mussi, C Bonifati, et al.
The Journal of Dermatological Treatment|April 16, 2019
Effectiveness of etanercept biosimilar SB4 in maintaining low disease activity in patients with psoriatic arthritis switched from etanercept originator: an open-label one year studyC Bonifati, C De Felice, V Lora, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 30, 2008
[Evidence-based guidelines and nephrological clinical practice: the GRADE system for rating of evidence]C Bonifati, G F M Strippoli, C Manno, et al.
Acta Dermato-Venereologica. Supplementum|January 1, 1994
Soluble intercellular adhesion molecule-1 and procollagen III peptide are reliable markers of disease severity in psoriasisF Ameglio, C Bonifati, M Carducci, et al.
The British Journal of Dermatology|October 9, 1998
Bullous pemphigoid blisters of the same duration have similar cytokine concentrations which decrease in older blistersB Giacalone, L D'Auria, C Ferraro, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 18, 2024
Upadacitinib in the treatment of difficult-to-treat psoriatic arthritisD Graceffa, F Sperati, V Lora, et al.
Acta Dermato-Venereologica. Supplementum|January 1, 1994
Interleukin-1-beta, interleukin-6, and interferon-gamma in suction blister fluids of involved and uninolved skin and in sera of psoriatic patientsC Bonifati, F Ameglio, M Carducci, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Clinical and Experimental Dermatology|December 3, 2014
Clinical remission of psoriatic arthritis in patients receiving continuous biological therapies for 1 year: the experience of an outpatient dermatological clinic for psoriasisD Graceffa, E Maiani, I Sperduti, et al.
Journal of Biological Regulators and Homeostatic Agents|May 16, 1998
IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skinC Bonifati, M Carducci, A Mussi, et al.
Drugs & Aging|April 16, 1998
Recognition and treatment of psoriasis. Special considerations in elderly patientsC Bonifati, M Carducci, A Mussi, et al.
Archives of Dermatological Research|January 1, 1994
sICAM-1, sIL-2R and beta 2-microglobulin serum levels in patients affected with psoriasis: relationship with disease severityM Carducci, A Mussi, C Bonifati, et al.
The Journal of Dermatological Treatment|April 16, 2019
Effectiveness of etanercept biosimilar SB4 in maintaining low disease activity in patients with psoriatic arthritis switched from etanercept originator: an open-label one year studyC Bonifati, C De Felice, V Lora, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 30, 2008
[Evidence-based guidelines and nephrological clinical practice: the GRADE system for rating of evidence]C Bonifati, G F M Strippoli, C Manno, et al.
Acta Dermato-Venereologica. Supplementum|January 1, 1994
Soluble intercellular adhesion molecule-1 and procollagen III peptide are reliable markers of disease severity in psoriasisF Ameglio, C Bonifati, M Carducci, et al.
The British Journal of Dermatology|October 9, 1998
Bullous pemphigoid blisters of the same duration have similar cytokine concentrations which decrease in older blistersB Giacalone, L D'Auria, C Ferraro, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 18, 2024
Upadacitinib in the treatment of difficult-to-treat psoriatic arthritisD Graceffa, F Sperati, V Lora, et al.
Acta Dermato-Venereologica. Supplementum|January 1, 1994
Interleukin-1-beta, interleukin-6, and interferon-gamma in suction blister fluids of involved and uninolved skin and in sera of psoriatic patientsC Bonifati, F Ameglio, M Carducci, et al.
Pageof 6